Format

Send to

Choose Destination
Cancer Immunol Immunother. 2019 Nov 27. doi: 10.1007/s00262-019-02409-6. [Epub ahead of print]

Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Author information

1
Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.
2
Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.
3
Faculty of Medicine, University of Oslo, 0316, Oslo, Norway.
4
Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway. sebastw@rr-research.no.
5
Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway. elsmar@rr-research.no.

Abstract

The original version of this article unfortunately included a mistake in Fig. 2b where the images of mice in the tumour control group (right), day 30 (bottom) should be removed as the wrong images (duplicate of day 17) were inserted by mistake. At this time point the tumour control mice were no longer alive and the images were replaced by black areas.

PMID:
31776597
DOI:
10.1007/s00262-019-02409-6

Supplemental Content

Full text links

Icon for Springer Icon for Norwegian BIBSYS system
Loading ...
Support Center